Thomas Hultsch

Author PubWeight™ 8.29^‹?›

Rank	Title	Journal	Year	PubWeight™‹?›
1	Pimecrolimus cream 1% in the treatment of intertriginous psoriasis: a double-blind, randomized study.	J Am Acad Dermatol	2004	1.36
2	Efficacy of combination treatment with anti-IgE plus specific immunotherapy in polysensitized children and adolescents with seasonal allergic rhinitis.	J Allergy Clin Immunol	2002	1.34
3	Efficacy and safety of pimecrolimus cream in the long-term management of atopic dermatitis in children.	Pediatrics	2002	1.22
4	Current management of atopic dermatitis and interruption of the atopic march.	J Allergy Clin Immunol	2003	1.11
5	Omalizumab therapy in atopic dermatitis: depletion of IgE does not improve the clinical course - a randomized, placebo-controlled and double blind pilot study.	J Dtsch Dermatol Ges	2010	0.88
6	Pimecrolimus enhances TLR2/6-induced expression of antimicrobial peptides in keratinocytes.	J Invest Dermatol	2008	0.88
7	Twice-daily versus once-daily applications of pimecrolimus cream 1% for the prevention of disease relapse in pediatric patients with atopic dermatitis.	Pediatr Dermatol	2009	0.80
8	Efficacy and safety of pimecrolimus cream 1% in mild-to-moderate chronic hand dermatitis: a randomized, double-blind trial.	Dermatology	2010	0.79
9	Addition of pimecrolimus cream 1% to a topical corticosteroid treatment regimen in paediatric patients with severe atopic dermatitis: a randomized, double-blind trial.	J Dermatolog Treat	2010	0.75